| . "Celecoxib with neoadjuvant chemotherapy for breast cancer might worsen outcomes differentially by COX-2 expression and ER status: Exploratory analysis of the REMAGUS02 trial.." J Clin Oncol. 2019;37(8):624-635. Pub Med |
| . "Missing data in clinical studies: Issues and methods.." J Clin Oncol. 2012;30(26):3297-303. Pub Med |
| . "Basic concepts and methods for joint models of longitudinal and survival data.." J Clin Oncol. 2010;28(16):2796-801. Pub Med |
| . "Clinical trials data collection: When less is more.." J Clin Oncol. 2010;28(34):5019-21. Pub Med |
| . "Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US National Cancer Institute Cooperative Group Studies.." J Clin Oncol. 2017;35(25):2885-2892. Pub Med |
| . "Clinical prognostic model for older patients with advanced non-small cell lung cancer.." J Geriatr Oncol. 2019;10(4):555-559. Pub Med |
| . "Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.." J Natl Cancer Inst. 2012;104(3):211-27. Pub Med |
| . "Network meta-analysis of margin threshold for women with ductal carcinoma in situ.." J Natl Cancer Inst. 2012;104(7):507-16. Pub Med |
| . "Reporting and guidelines in propensity score analysis: A systematic review of cancer and cancer surgical studies.." J Natl Cancer Inst. 2017;109(8):. Pub Med |
| . "Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology.." J Pharmacol Exp Ther. 2013;347(3):599-606. Pub Med |
| . "Increase in speech recognition due to linguistic mismatch between target and masker speech: monolingual and simultaneous bilingual performance.." J Speech Lang Hear Res. 2014;57(3):1089-97. Pub Med |
| . "Risk calculators are useful but....." J Thorac Cardiovasc Surg. 2016;151(3):706-707. Pub Med |
| . "Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer.." J Thorac Oncol. 2015;10(7):1099-106. Pub Med |
| . "Toxicity related to radiotherapy dose and targeting strategy: A pooled analysis of cooperative group trials of combined modality therapy for locally advanced non-small cell lung cancer.." J Thorac Oncol. 2019;14(2):298-303. Pub Med |
| . "Statistical considerations for subgroup analyses.." J Thorac Oncol. 2021;16(3):375-380. Pub Med |
| . "Development and validation of a natural language processing tool to generate the CONSORT reporting checklist for randomized clinical trials.." JAMA Netw Open. 2020;3(10):e2014661. Pub Med |
| . "Prospects and challenges for clinical decision support in the era of big data.." JCO Clin Cancer Inform. 2018;2():. Pub Med |
| . "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med |
| . "A junction coverage compatibility score to quantify the reliability of transcript abundance estimates and annotation catalogs.." Life Sci Alliance. 2019;2(1):. Pub Med |
| . "Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching.." Lifetime Data Anal. 2014;20(1):76-105. Pub Med |
| . "Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective.." Lifetime Data Anal. 2017;23(4):585-604. Pub Med |
| . "Multiplicative rates model for recurrent events in case-cohort studies.." Lifetime Data Anal. 2020;26(1):134-157. Pub Med |
| . "Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring.." Lifetime Data Anal. 2011;17(4):566-93. Pub Med |
| . "Quantifying the average of the time-varying hazard ratio via a class of transformations.." Lifetime Data Anal. 2015;21(2):259-79. Pub Med |
| . "Accelerated failure time model for data from outcome-dependent sampling.." Lifetime Data Anal. 2021;27(1):15-37. Pub Med |
| . "Marginal hazard regression for correlated failure time data with auxiliary covariates.." Lifetime Data Anal. 2012;18(1):116-38. Pub Med |
| . "Estimation of treatment effects and model diagnostics with two-way time-varying treatment switching: an application to a head and neck study.." Lifetime Data Anal. 2020;26(4):685-707. Pub Med |
| . "Proportional exponentiated link transformed hazards (ELTH) models for discrete time survival data with application.." Lifetime Data Anal. 2016;22(1):38-62. Pub Med |
| . "Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed.." Lifetime Data Anal. 2013;19(4):513-46. Pub Med |
| . "A regularized variable selection procedure in additive hazards model with stratified case-cohort design.." Lifetime Data Anal. 2018;24(3):443-463. Pub Med |
| . "Semiparametric additive marginal regression models for multiple type recurrent events.." Lifetime Data Anal. 2012;18(4):504-27. Pub Med |
| . "Semiparametric sieve maximum likelihood estimation under cure model with partly interval censored and left truncated data for application to spontaneous abortion.." Lifetime Data Anal. 2019;25(3):507-528. Pub Med |
| . "Joint modeling of survival time and longitudinal outcomes with flexible random effects.." Lifetime Data Anal. 2018;24(1):126-152. Pub Med |
| . "Recent progresses in outcome-dependent sampling with failure time data.." Lifetime Data Anal. 2017;23(1):57-82. Pub Med |
| . "Semiparametric inference for a two-stage outcome-dependent sampling design with interval-censored failure time data.." Lifetime Data Anal. 2020;26(1):85-108. Pub Med |
| . "Predicting risk of chemotherapy-induced severe neutropenia: A pooled analysis in individual patients data with advanced lung cancer.." Lung Cancer. 2020;141():14-20. Pub Med |
| . "Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups.." Lung Cancer. 2015;90(2):281-7. Pub Med |
| . "Simulation of brain mass effect with an arbitrary Lagrangian and Eulerian FEM.." Med Image Comput Comput Assist Interv. 2010;13(Pt 2):274-81. Pub Med |
| . "Multivariate network-level approach to detect interactions between large-scale functional systems.." Med Image Comput Comput Assist Interv. 2010;13(Pt 2):298-305. Pub Med |
| . "Multivariate varying coefficient models for DTI tract statistics.." Med Image Comput Comput Assist Interv. 2010;13(Pt 1):690-7. Pub Med |
| . "The long noncoding RNA promotes sarcoma metastasis by regulating RNA splicing pathways.." Mol Cancer Res. 2020;18(10):1534-1544. Pub Med |
| . "Static and dynamic DNA loops form AP-1-bound activation hubs during macrophage development.." Mol Cell. 2017;67(6):1037-1048.e6. Pub Med |
| . "Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy.." Nat Commun. 2020;11(1):6410. Pub Med |
| . "Genome-wide association study identifies five new schizophrenia loci.." Nat Genet. 2011;43(10):969-76. Pub Med |
| . "Genetic analyses of diverse populations improves discovery for complex traits.." Nature. 2019;570(7762):514-518. Pub Med |
| . "Multiscale adaptive generalized estimating equations for longitudinal neuroimaging data.." Neuroimage. 2013;72():91-105. Pub Med |
| . "SGPP: Spatial Gaussian predictive process models for neuroimaging data.." Neuroimage. 2014;89():70-80. Pub Med |
| . "SMAC: Spatial multi-category angle-based classifier for high-dimensional neuroimaging data.." Neuroimage. 2018;175():230-245. Pub Med |
| . "Semiparametric Bayesian local functional models for diffusion tensor tract statistics.." Neuroimage. 2012;63(1):460-74. Pub Med |
| . "Longitudinal regression analysis of spatial-temporal growth patterns of geometrical diffusion measures in early postnatal brain development with diffusion tensor imaging.." Neuroimage. 2011;58(4):993-1005. Pub Med |
